Development of Fibrates as Important Scaffolds in Medicinal Chemistry

ChemMedChem. 2019 Jun 5;14(11):1051-1066. doi: 10.1002/cmdc.201900128. Epub 2019 May 7.

Abstract

Fibrates are a class of phenoxyisobutyric acid derivatives mainly used as anti-hyperlipidemic agents. The fibrate scaffold has undergone a variety of chemical modifications, providing a wide spectrum of biological activities. Within the last few years, the majority of new synthetic fibrate derivatives have demonstrated hypolipidemic activity through peroxisome proliferator-activated receptor α (PPARα) activation. However, some compounds containing the fibrate scaffold have shown different pharmacological properties, also independent of PPARα activation, such as anti-inflammatory, analgesic, antioxidant, and antiplatelet activities. The aim of this review is to highlight the structure-activity relationships (SAR) in evaluating the significance of fibrates in the field of medicinal chemistry.

Keywords: PPARs; fibrates; hybrids; hypolipidemic agents; phenoxypropanoic acid.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Chemistry, Pharmaceutical
  • Fibric Acids / chemical synthesis
  • Fibric Acids / chemistry*
  • Fibric Acids / pharmacology*
  • Humans
  • Hyperlipidemias / drug therapy
  • Hyperlipidemias / metabolism
  • Hypolipidemic Agents / chemical synthesis
  • Hypolipidemic Agents / chemistry*
  • Hypolipidemic Agents / pharmacology*
  • Molecular Structure
  • PPAR alpha / metabolism
  • Structure-Activity Relationship

Substances

  • Fibric Acids
  • Hypolipidemic Agents
  • PPAR alpha